Familial Occurrence of Pulmonary Embolism after Intravenous, Adipose Tissue-Derived Stem Cell Therapy

Abstract

The therapeutic potential of human multipotent mesenchymal stromal cells, especially human adipose tissue-derived stem cells (hASC), is promising. However, there are concerns about the safety of infusion of hASC in human. Recently, we have experienced pulmonary embolism and infarct among family members who have taken multiple infusions of intravenous autologous hASC therapy. A 41-year-old man presented with chest pain for one month. Chest CT showed multiple pulmonary artery embolism and infarct at right lung. Serum D-dimer was 0.8 µg/mL (normal; 0-0.5 µg/mL). He had received intravenous autologous adipose tissue-derived stem cell therapy for cervical herniated intervertebral disc three times (one, two, and three months prior to the visit). His parents also received the same therapy five times and their chest CT also showed multiple pulmonary embolism. These cases represent artificial pulmonary embolisms and infarct after IV injection of hASC. Follow-up chest CT showed spontaneous resolution of lesions in all three patients.

Stromal cells–are they really useful for GVHD?

“…104 Patients treated with stromal cells need to be followed closely for the possible risk of tumor formation. 25,26,[105][106][107][108] When taking all clinical observations into consideration, we still believe that stromal cell therapy can be useful for GVHD, particularly in children.…”

Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation – single center experience

“…28 When infused in portal circulation, stem cells stay in hepatic microcirculation leading to a chain of tolerogenic events for induction and maintenance of tolerance. It believed to be related to switching from Th1 to Th2 cells with consequent changes in the cytokine milieu favoring levels of IL4 and IL10 thereby preventing rejection.…”

Unproven Stem Cell Treatments for Lung Disease—An Emerging Public Health Problem

“…Potential risks include cell embolism (stem cells clotting in the lungs) and the cells causing abnormal growth including tumors 5,6 . In addition, a number of clinics are giving treatment in ways that do not meet normal standards of sterility (to prevent infection) and safety.…”